Atlas Trials

Practical Usability of EGFR Mutation Detection in ctDNA From Resectable NSCLC

Clinical trial NCT04922073 · UNKNOWN

Trial details

NCT number
NCT04922073
Sponsor
Samsung Medical Center
Status
UNKNOWN
Study type
OBSERVATIONAL
Lung Neoplasms
Start date
2021-06-01
Primary completion
2022-01-31
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.